| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sareh Shahmohammadi, Rozita Doosti, Abootorab Shahmohammadi, Seyed Ehsan Mohammadianinejad, Mohammad Ali Sahraian, Amir Reza Azimi, Mohammad Hossein Harirchian, Nasrin Asgari, Abdorreza Naser Moghadas. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review. Multiple sclerosis and related disorders. vol 27. 2019-04-04. PMID:30476871. |
neuromyelitis optica (nmo) is an autoimmune inflammatory demyelinating disease of the central nervous system (cns) which predominantly involves optic nerves and spinal cord. |
2019-04-04 |
2023-08-13 |
Not clear |
| Yan Wu, Lianmei Zhong, Jia Gen. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models. Multiple sclerosis and related disorders. vol 27. 2019-04-04. PMID:30530071. |
neuromyelitis optica (nmo) and nmo spectrum disorder (nmosd) are inflammatory cns syndromes mainly involving the optic nerve and/or spinal cord and characterized by the presence of serum aquaporin-4 immunoglobulin g antibodies (aqp4-igg). |
2019-04-04 |
2023-08-13 |
mouse |
| Scott S Zamvil, Collin M Spencer, Sergio E Baranzini, Bruce A C Cre. The Gut Microbiome in Neuromyelitis Optica. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. vol 15. issue 1. 2019-03-13. PMID:29280091. |
neuromyelitis optica (nmo) is a rare, disabling, sometimes fatal central nervous system inflammatory demyelinating disease that is associated with antibodies ("nmo igg") that target the water channel protein aquaporin-4 (aqp4) expressed on astrocytes. |
2019-03-13 |
2023-08-13 |
human |
| Samila Alves Silva, Patrícia Silva Cunha, Araceli Santos Brito, Rosana Barros Souza, Sandra Lúcia Euzébio Ribeir. Devic's syndrome and mixed connective tissue disease: an unusual association. Acta reumatologica portuguesa. vol 43. issue 2. 2019-02-22. PMID:30091958. |
devic's disease or neuromyelitis optica (nmo) is an autoimmune, inflammatory and demyelinating pathology of the central nervous system that affects the optic nerve and the spinal cord. |
2019-02-22 |
2023-08-13 |
Not clear |
| Sami Bennji, Diaeddin Sagar, Naeem Brey, Coenraad Koegelenber. Neuromyelitis optica with unilateral diaphragmatic paralysis. BMJ case reports. vol 2018. 2019-01-31. PMID:30269091. |
in this case report, we describe the course of a female patient who is known to have neuromyelitis optica (nmo) and developed left hemiparesis and unilateral diaphragmatic paralysis. |
2019-01-31 |
2023-08-13 |
Not clear |
| K Apetse, K Assogba, J E Diatewa, J J Dongmo Tajeuna, N Maneh, F M Tassa Kayem, D Kombate, K A Balogo. Neuromyelitis optica in Sub-Saharan Africa: the first case report from Togo. Medecine et sante tropicales. vol 28. issue 2. 2019-01-30. PMID:29798830. |
neuromyelitis optica (nmo) appears to affect blacks disproportionately in mixed populations. |
2019-01-30 |
2023-08-13 |
Not clear |
| Mai Kikumoto, Megumi Nonaka, Jun Takeshita, Tomohiko Ohshita, Hiroshi Yamashit. [Elderly onset case of neuromyelitis optica that developed at the age of 90]. Rinsho shinkeigaku = Clinical neurology. vol 58. issue 12. 2019-01-30. PMID:30487360. |
we report a case of neuromyelitis optica (nmo) that was diagnosed at the age of 90. |
2019-01-30 |
2023-08-13 |
Not clear |
| Reinhard Hohlfel. B-cells as therapeutic targets in neuro-inflammatory diseases. Clinical immunology (Orlando, Fla.). vol 186. 2019-01-25. PMID:28736276. |
in autoantibody-associated demyelinating syndromes such as neuromyelitis optica (nmo) and in myelin-oligodendrocyte-glycoprotein-(mog)-autoantibody-associated encephalomyelitis, b-cells are a logical target based on the pathogenesis of these antibody-mediated disorders. |
2019-01-25 |
2023-08-13 |
Not clear |
| E Antonio-Luna, G I Acosta-Castillo, J F Ortiz-Maldonado, A Estrada-Galindo, T Corona, J Flore. [Comparison of neuromyelitis optica spectra according to AQP4 antibody serostatus in a Mexican referral centre]. Revista de neurologia. vol 65. issue 7. 2019-01-02. PMID:28929473. |
recent studies report that patients with neuromyelitis optica (nmo) or seropositive nmo spectra disorders display clinical characteristics that are different from those of patients who are seropositive for the aquaporin-4 (aqp4) antibody. |
2019-01-02 |
2023-08-13 |
Not clear |
| Guillermo Delgado-García, Zoé Chávez, Verónica Rivas-Alonso, Teresa Corona, José Flores-River. Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica. Multiple sclerosis and related disorders. vol 25. 2018-12-18. PMID:30149303. |
previous studies have investigated the influence of neuromyelitis optica (nmo) on pregnancy in other ethnic groups. |
2018-12-18 |
2023-08-13 |
Not clear |
| Tianjiao Duan, Alex J Smith, Alan S Verkma. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica. Journal of neuroinflammation. vol 15. issue 1. 2018-12-18. PMID:30348195. |
aquaporin-4-immunoglobulin g (aqp4-igg) seropositive neuromyelitis optica spectrum disorder (herein called nmo) is an autoimmune disease of the central nervous system in which aqp4-igg binding to aqp4 on astrocytes results in complement-dependent astrocyte injury and secondary inflammation, demyelination, and neuron loss. |
2018-12-18 |
2023-08-13 |
Not clear |
| Regina Maria Papais-Alvarenga, Vanderson Carvalho Neri, Ana Carolina Ribeiro de Araújo E Araújo, Elizabeth Batista da Silva, Marcos Papais Alvarenga, Ana Beatriz Calmon Nogueira da Gama Pereira, Anna Christiany Brandão, Helcio Alvarenga-Filho, Marcell Pourbaix Morisson Guimarães, Romain Marignier, Priscila Oliveira Barros, Cleonice Melo Bento, Claudia Cristina Ferreira Vasconcelo. Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence? Multiple sclerosis and related disorders. vol 25. 2018-12-13. PMID:30056361. |
antibodies against myelin oligodendrocyte glycoprotein (mog-ab) have been investigated as potential biological marker for neuromyelitis optica (nmo) and high-risk syndromes (hr) negative for aqp4-ab in populations with different ethnic background. |
2018-12-13 |
2023-08-13 |
Not clear |
| Cong Zhao, Tao Liu, Chao Ma, Hongzeng Li, Zhuyi Li, Jun Gu. Azathioprine-induced pellagra in neuromyelitis optica: A case report and review of literature. Multiple sclerosis and related disorders. vol 25. 2018-12-13. PMID:30059893. |
neuromyelitis optica (nmo), also known as devic's disease, is a classical autoimmune disorder of the central nervous system (cns). |
2018-12-13 |
2023-08-13 |
Not clear |
| G Mathey, M Michaud, S Pittion-Vouyovitch, M Debouveri. Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today? Revue neurologique. vol 174. issue 6. 2018-12-11. PMID:29673575. |
this article reviews the various classifications of the forms and diagnostic criteria of ms and related syndromes, including neuromyelitis optica (nmo)/nmo spectrum disorders (nmosds), acute disseminated (demyelinating) encephalomyelitis (adem) and chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (clippers). |
2018-12-11 |
2023-08-13 |
Not clear |
| Karol Estrada, Christopher W Whelan, Fengmei Zhao, Paola Bronson, Robert E Handsaker, Chao Sun, John P Carulli, Tim Harris, Richard M Ransohoff, Steven A McCarroll, Aaron G Day-Williams, Benjamin M Greenberg, Daniel G MacArthu. A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nature communications. vol 9. issue 1. 2018-12-11. PMID:29769526. |
neuromyelitis optica (nmo) is a rare autoimmune disease that affects the optic nerve and spinal cord. |
2018-12-11 |
2023-08-13 |
Not clear |
| Brett Alldredge, Allison Jordan, Jaime Imitola, Michael K Rack. Safety and Efficacy of Rituximab: Experience of a Single Multiple Sclerosis Center. Clinical neuropharmacology. vol 41. issue 2. 2018-11-27. PMID:29389745. |
b cells play an important pathogenic role in ms. rituximab (rtx), a b-cell depleting drug, has been used to treat ms and neuromyelitis optica (nmo). |
2018-11-27 |
2023-08-13 |
Not clear |
| Kana Harada, Yuki Fujita, Tatsusada Okuno, Shogo Tanabe, Yoshihisa Koyama, Hideki Mochizuki, Toshihide Yamashit. Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica. Scientific reports. vol 8. issue 1. 2018-11-21. PMID:29311561. |
neuromyelitis optica (nmo) is an autoimmune disease associated with nmo immunoglobulin g (nmo-igg), an antibody that selectively binds to the aquaporin-4. |
2018-11-21 |
2023-08-13 |
rat |
| Lukmanee Tradtrantip, Christian M Felix, Rolf Spirig, Adriana Baz Morelli, A S Verkma. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica. Neuropharmacology. vol 133. 2018-11-05. PMID:29428821. |
intravenous human immunoglobulin g (ivig) may have therapeutic benefit in neuromyelitis optica spectrum disorders (herein called nmo), in part because of the anti-inflammatory properties of the igg fc region. |
2018-11-05 |
2023-08-13 |
human |
| Mário Luiz R Monteiro, Kenzo Hokazono, Leonardo P Cunha, Laurentino Biccas Net. Acute visual loss and optic disc edema followed by optic atrophy in two cases with deeply buried optic disc drusen: a mimicker of atypical optic neuritis. BMC ophthalmology. vol 18. issue 1. 2018-11-05. PMID:30367617. |
however, little or no recovery occurs when the loss is caused by atypical on, especially in patients with neuromyelitis optica (nmo). |
2018-11-05 |
2023-08-13 |
Not clear |
| Francesco Pisani, Laura Simone, Concetta Domenica Gargano, Manuela De Bellis, Antonio Cibelli, Maria Grazia Mola, Giacomo Catacchio, Antonio Frigeri, Maria Svelto, Grazia Paola Nicchi. Role of the H-bond between L53 and T56 for Aquaporin-4 epitope in Neuromyelitis Optica. Biochimica et biophysica acta. Biomembranes. vol 1859. issue 3. 2018-11-02. PMID:28027883. |
neuromyelitis optica (nmo) is an autoimmune disease caused by anti-oap autoantibodies (aqp4-igg). |
2018-11-02 |
2023-08-13 |
Not clear |